These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 16679868)
1. Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial. Yang HP; Woodson K; Taylor PR; Pietinen P; Albanes D; Virtamo J; Tangrea JA Eur J Cancer Prev; 2006 Jun; 15(3):249-53. PubMed ID: 16679868 [TBL] [Abstract][Full Text] [Related]
2. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk. Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Kamangar F; Abnet CC; Hutchinson AA; Newschaffer CJ; Helzlsouer K; Shugart YY; Pietinen P; Dawsey SM; Albanes D; Virtamo J; Taylor PR Cancer Causes Control; 2006 Feb; 17(1):117-25. PubMed ID: 16411061 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease. Duymaz-Tozkir J; Yilmaz V; Uyar FA; Hajeer AH; Saruhan-Direskeneli G; Gül A J Rheumatol; 2005 Jan; 32(1):93-7. PubMed ID: 15630732 [TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Wei YS; Lan Y; Tang RG; Xu QQ; Huang Y; Nong HB; Huang WT Clin Immunol; 2007 Dec; 125(3):309-17. PubMed ID: 17720627 [TBL] [Abstract][Full Text] [Related]
6. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Smith KC; Bateman AC; Fussell HM; Howell WM Eur J Immunogenet; 2004 Aug; 31(4):167-73. PubMed ID: 15265021 [TBL] [Abstract][Full Text] [Related]
7. Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer. Kamali-Sarvestani E; Aliparasti MR; Atefi S Neoplasma; 2007; 54(6):484-9. PubMed ID: 17949231 [TBL] [Abstract][Full Text] [Related]
8. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Xu J; Lowey J; Wiklund F; Sun J; Lindmark F; Hsu FC; Dimitrov L; Chang B; Turner AR; Liu W; Adami HO; Suh E; Moore JH; Zheng SL; Isaacs WB; Trent JM; Grönberg H Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2563-8. PubMed ID: 16284379 [TBL] [Abstract][Full Text] [Related]
9. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer. Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386 [TBL] [Abstract][Full Text] [Related]
10. Influence of MUC1 genetic variation on prostate cancer risk and survival. Strawbridge RJ; Nister M; Brismar K; Li C; Lindström S Eur J Hum Genet; 2008 Dec; 16(12):1521-5. PubMed ID: 18628787 [TBL] [Abstract][Full Text] [Related]
11. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345 [TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk. Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort. Kesarwani P; Mandhani A; Mittal RD J Urol; 2009 Dec; 182(6):2938-43. PubMed ID: 19846139 [TBL] [Abstract][Full Text] [Related]
14. Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Murphy C; McGurk M; Pettigrew J; Santinelli A; Mazzucchelli R; Johnston PG; Montironi R; Waugh DJ Clin Cancer Res; 2005 Jun; 11(11):4117-27. PubMed ID: 15930347 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Choi JY; Neuhouser ML; Barnett M; Hudson M; Kristal AR; Thornquist M; King IB; Goodman GE; Ambrosone CB Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1115-20. PubMed ID: 17548672 [TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphisms in the coding regions of human CXC-chemokine receptors CXCR1, CXCR2 and CXCR3. Kato H; Tsuchiya N; Tokunaga K Genes Immun; 2000 Jun; 1(5):330-7. PubMed ID: 11196695 [TBL] [Abstract][Full Text] [Related]
17. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA. Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173 [TBL] [Abstract][Full Text] [Related]
18. IL-8 (-251 A/T) and CXCR2 (+1208 C/T) gene polymorphisms and risk of multiple sclerosis in Iranian patients. Kamali-Sarvestani E; Nikseresht AR; Aliparasti MR; Vessal M Neurosci Lett; 2006 Aug; 404(1-2):159-62. PubMed ID: 16793206 [TBL] [Abstract][Full Text] [Related]
19. Utility of incorporating genetic variants for the early detection of prostate cancer. Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501 [TBL] [Abstract][Full Text] [Related]
20. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development. Lindström S; Wiklund F; Adami HO; Bälter KA; Adolfsson J; Grönberg H Cancer Res; 2006 Nov; 66(22):11077-83. PubMed ID: 17108148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]